Volume 22, Issue 1 (September 1998)                   Research in Medicine 1998, 22(1): 65-70 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Azizi F. Comparison of Two Propylthiouracil Preparations in Treatment of Toxic Goiter. Research in Medicine. 1998; 22 (1) :65-70
URL: http://pejouhesh.sbmu.ac.ir/article-1-2231-en.html
Endocrine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Abstract:   (1111 Views)
In order to compare the effect of propylthiouracil (PTU) of Iran Hormone Co. and that of Dr. Herbrand KG, Germany, 28 patients with toxic goiter entered this study. Each patient received 200 mg PTU daily for the first 4 weeks and 50 mg daily thereafter. 17 patients received PTU from Iran Hormone (group 1) and 111 took PTU from Germany (group 2). T4, T3 and TSH by RIA and resine T3, uptake were measured by commercial kits before and 2, 4 and 8 weeks after therapy. 4 weeks after PTU treatment, T4. decreased from 19.1±5.3 to 9.2±3.3 (group 1) and from 21.0±1.5 to 8.9±2.2 µg/dl (group 2); T3, decreased from 462±181 to 197±52
 (group 1) and from 426±189 to 182±63 ng/dl (group 2): all changes P<0.001. 8 weeks after therapy serum Ty increased in both groups: 262±43 and 220±53 ng/dl, respectively; but no changes in serum T4 occured. There was no significant difference between effects of two PTU preparation in T4, T3; and TSH up to 8 weeks. It is concluded that PTU preparation of Tran Hormone is effective in treatment of toxic goiter and compares well with German preparation. Recommended dosage of PTU would be 300 mg daily for the first and 100 mg daily for the second month of therapy.
Full-Text [PDF 2521 kb]   (302 Downloads)    
Type of Study: Original | Subject: Interdisciplinary (Educational Management, Educational research, Statistics, Medical education
Received: 2020/02/18 | Accepted: 2020/02/18 | Published: 2020/02/18

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Creative Commons License
This Journal is licensed under a Creative Commons Attribution 4.0 International License  | Research in Medicine

Designed & Developed by : Yektaweb